Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders ...

Axsome Therapeutics and Hetero Labs agreed to settle to resolve patent litigation claims. The litigation, which is pending in a New Jersey district court, resulted from Hetero submitting an ...

Viatris Inc. , a global healthcare company, today announced the launch in Canada of Gen-Clozapine orally disintegrating tablets (ODT) (12.5 mg, 25 mg, 50 mg, 100 mg and 200 mg), providing a new ...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") , a Canadian healthcare and clinical stage drug development company, is pleased to announce a non-brokered private placement for gross ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central ...

In the first quarter, the Lazard US Equity Concentrated Portfolio underperformed its benchmark, the S&P 500 Index. Read more here.